Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2017 from OUS - Center for Clinical Heart Research

23 publications found

Abdelnoor M, Andersen JG, Arnesen H, Johansen O (2017)
Early discharge compared with ordinary discharge after percutaneous coronary intervention - a systematic review and meta-analysis of safety and cost
Vasc Health Risk Manag, 13, 101-109
DOI 10.2147/VHRM.S122951, PubMed 28356750

Bratseth V, Byrkjeland R, Njerve IU, Solheim S, Arnesen H, Seljeflot I (2017)
Procoagulant activity in patients with combined type 2 diabetes and coronary artery disease: No effects of long-term exercise training
Diab Vasc Dis Res, 14 (2), 144-151
DOI 10.1177/1479164116679080, PubMed 28111966

Byrkjeland R, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2017)
Reduced endothelial activation after exercise is associated with improved HbA1c in patients with type 2 diabetes and coronary artery disease
Diab Vasc Dis Res, 14 (2), 94-103
DOI 10.1177/1479164116679077, PubMed 28111980

Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2017)
Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
PLoS One, 12 (2), e0172558
DOI 10.1371/journal.pone.0172558, PubMed 28207887

Cwikiel J, Seljeflot I, Berge E, Arnesen H, Wachtell K, Ulsaker H, Flaa A (2017)
Pro-coagulant activity during exercise testing in patients with coronary artery disease
Thromb J, 15, 3
DOI 10.1186/s12959-016-0127-8, PubMed 28115916

Ellingsen DG, Seljeflot I, Thomassen Y, Thomassen M, Bakke B, Ulvestad B (2017)
Biomarkers of endothelial activation and thrombosis in tunnel construction workers exposed to airborne contaminants
Int Arch Occup Environ Health, 90 (4), 309-317
DOI 10.1007/s00420-017-1199-x, PubMed 28124139

Gharagozlian S, Hansen R, Haugen M, Johansen O, Seierstad SL, Seljeflot I, Arnesen H (2017)
Changes in dietary pattern when including 700 g of salmon per week to patients with atherosclerotic heart disease
Clin. Nutr. ESPEN, 19, 38-44

Heier M, Borja MS, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K, Oda MN (2017)
Reduced HDL function in children and young adults with type 1 diabetes
Cardiovasc Diabetol, 16 (1), 85
DOI 10.1186/s12933-017-0570-2, PubMed 28683835

Horjen AW, Seljeflot I, Berge T, Smith P, Arnesen H, Tveit A (2017)
Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation
Thromb J, 15, 30
DOI 10.1186/s12959-017-0153-1, PubMed 29299030

Hove-Skovsgaard M, Gaardbo JC, Kolte L, Winding K, Seljeflot I, Svardal A, Berge RK, Gerstoft J, Ullum H, Trøseid M, Nielsen SD (2017)
HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
BMC Infect Dis, 17 (1), 234
DOI 10.1186/s12879-017-2334-8, PubMed 28356058

Husebye T, Eritsland J, Bjørnerheim R, Andersen GØ (2017)
Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure
Eur Heart J Acute Cardiovasc Care, 7 (4), 321-329
DOI 10.1177/2048872616687114, PubMed 28045338

Kvakkestad KM, Sandvik L, Andersen GØ, Sunde K, Halvorsen S (2017)
Long-term survival in patients with acute myocardial infarction and out-of-hospital cardiac arrest: A prospective cohort study
Resuscitation, 122, 41-47
DOI 10.1016/j.resuscitation.2017.11.047, PubMed 29155294

Lie I, Danielsen SO, Tønnessen T, Solheim S, Leegaard M, Sandvik L, Wisløff T, Vangen J, Røsstad TH, Moons P (2017)
Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial
Trials, 18 (1), 246
DOI 10.1186/s13063-017-1971-y, PubMed 28693599

Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Norseth J, Arnesen H, Solheim S (2017)
Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study
JRSM Cardiovasc Dis, 6, 2048004017729984
DOI 10.1177/2048004017729984, PubMed 28932392

Mariampillai JE, Engeseth K, Kjeldsen SE, Grundvold I, Liestøl K, Erikssen G, Erikssen J, Bodegard J, Skretteberg PT (2017)
Exercise systolic blood pressure at moderate workload predicts cardiovascular disease and mortality through 35 years of follow-up in healthy, middle-aged men
Blood Press, 26 (4), 229-236
DOI 10.1080/08037051.2017.1291276, PubMed 28276720

Myhre PL, Stridsberg M, Linko R, Okkonen M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H, FINNALI Study Group (2017)
Circulating chromogranin B levels in patients with acute respiratory failure: data from the FINNALI Study
Biomarkers, 22 (8), 775-781
DOI 10.1080/1354750X.2016.1269200, PubMed 28049363

Njerve IU, Åkra S, Weiss TW, Solheim S, Øvstebø R, Aass HCD, Byrkjeland R, Arnesen H, Seljeflot I (2017)
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
Mediators Inflamm, 2017, 5380638
DOI 10.1155/2017/5380638, PubMed 28596642

Opstad TB, Seljeflot I, Bøhmer E, Arnesen H, Halvorsen S (2017)
MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy
Cardiology, 139 (1), 17-24
DOI 10.1159/000481684, PubMed 29141241

Prestgaard E, Hodnesdal C, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen SE, Grundvold I, Berge E (2017)
Long-term predictors of stroke in healthy middle-aged men
Int J Stroke, 13 (3), 292-300
DOI 10.1177/1747493017730760, PubMed 28929941

Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
Sci Rep, 7 (1), 11945
DOI 10.1038/s41598-017-12372-w, PubMed 28931920

Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
PLoS One, 12 (3), e0173034
DOI 10.1371/journal.pone.0173034, PubMed 28253327

Warlo EMK, Pettersen AR, Arnesen H, Seljeflot I (2017)
vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
Thromb J, 15, 28
DOI 10.1186/s12959-017-0151-3, PubMed 29200971

Wexels F, Dahl OE, Pripp AH, Seljeflot I (2017)
Thrombin Generation in Patients With Suspected Venous Thromboembolism
Clin Appl Thromb Hemost, 23 (5), 416-421
DOI 10.1177/1076029617700999, PubMed 28335612

 
Page visits: 347100